# clm_68A37D10302E

subject: Amgen (/record/amgen.md)  
predicate: total_equity  
value: 916,000,000 United States dollar  
valid_from: 2022-03-31  
valid_to: 2022-06-30  
published: 2022-04-28  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_4BB765E7F1FC  
last_updated: 2026-11-08  
cite: AsOf. "Amgen total equity: 916,000,000 United States dollar", as of 2022-03-31 (until 2022-06-30). Claim clm_68A37D10302E, https://asof.is/claim/clm_68A37D10302E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815422000021/0000318154-22-000021-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q1 FY2022, filed 2022-04-28  

## Sources

- https://www.sec.gov/Archives/edgar/data/318154/000031815422000021/0000318154-22-000021-index.htm (primary, SEC EDGAR 10-Q Q1 FY2022, published 2022-04-28)

## Supersedes

- [Amgen](/record/amgen.md) | total_equity | 6,700,000,000 United States dollar | valid 2021-12-31 to 2022-03-31 | conf 0.95 | superseded | superseded_by [clm_68A37D10302E](/claim/clm_68A37D10302E.md) | [clm_BF8A71350904](/claim/clm_BF8A71350904.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.